Activation of T cells by cross‐linking an anti‐CD3 antibody with a second anti‐T cell antibody: mechanism and subset‐specific activation
- 1 January 1987
- journal article
- research article
- Published by Wiley in European Journal of Immunology
- Vol. 17 (6) , 873-880
- https://doi.org/10.1002/eji.1830170622
Abstract
Binding of anti‐CD3 antibody BMA030‐F(ab′)2 to T cells is not able to induce T cell proliferation even after additional cross‐linking by plastic‐bound goat anti‐mouse Ig antibodies (panning) and addition of either interleukin (IL)1 or IL2. In search for agents able to complement the signals provided by BMA030‐F(ab′)2, several antibodies directed against CD2, CD4, CD5, CD6 and CD8 were used. Neither of these caused T cell proliferation either by themselves or when simply added together with BMA030‐F(ab′)2. However, if BMA030‐F(ab′)2 and any other of these anti‐CD2, CD4, CD5, CD6 or CD8 antibodies were cross‐linked, then proliferation of T cells occurred. The mitogenic effect of cross‐linking BMA030‐F(ab′)2 and a second anti‐T cell antibody is dependent on the presence of monocytes or exogenously added IL2. The enhancing effect of monocytes could not be replaced by addition of IL1, suggesting that other soluble factors or monocyte contact might be involved in induction of activation signals. The mechanism leading to this mitogenic effect is dependent on combining cross‐linking of BMA030 with the second anti‐T cell antibody, whereby the second antibody appears to act as an “anchor” for the CD3 antibody, controlling and/or changing the signal transduction via the CD3 structure. This “anchor” hypothesis could be substantiated by the following observations: (a) the best stimulatory signals were obtained at a BMA030/anti‐T cell antibody ratio of 1:1; (b) the effect is independent of the antibody isotype and the epitope recognized by the second antibody; (c) the binding of BMA030 and separate cross‐linking of the anti‐T cell antibody was not sufficient to trigger T cell mitogenesis; (d) immobilization by direct binding of the CD3 antibody alone or of the CD3 and second membrane structure/antibody complex separately was not sufficient to stimulate T cell proliferation. A further interesting aspect of this finding is the fact that a selective T cell stimulation is possible, since cross‐linking BMA030‐F(ab′)2 plus anti‐CD4 antibodies induced a selective stimulation of T4 cells, while cross‐linking BMA030‐F(ab′)2 plus anti‐CD8 activated solely T8 cells. It is thus possible to selectively activate T cell subsets in vitro.This publication has 39 references indexed in Scilit:
- Analysis of CD3-antibody-mediated inhibition of T-cell activationCellular Immunology, 1986
- T cell stimulation via the erythrocyte receptor. Synergism between monoclonal antibodies and phorbol myristate acetate without changes of free cytoplasmic Ca++ levels.The Journal of Experimental Medicine, 1986
- T cell activation by anti‐T3 antibodies: Comparison of IgG1 and IgG2b switch variants and direct evidence for accessory function of macrophage Fc receptorsEuropean Journal of Immunology, 1986
- Characterization of T8 epitopes by enzymatic digestion, cross-blocking, and involvement in cell-mediated lympholysisCellular Immunology, 1985
- Perturbation of the T4 molecule transmits a negative signal to T cells.The Journal of Experimental Medicine, 1985
- Mechanisms by which accessory cells contribute in growth of resting T lymphocytes initiated by OKT3 antibodyEuropean Journal of Immunology, 1985
- Inhibition of lymphocyte proliferation by monoclonal antibody directed against the T3 antigen on human T cellsCellular Immunology, 1984
- Possible involvement of the T4 molecule in T cell recognition of class II HLA antigens. Evidence from studies of CTL-target cell binding.The Journal of Experimental Medicine, 1984
- Evidence for the T3-associated 90K heterodimer as the T-cell antigen receptorNature, 1983
- Antigen recognition by human T lymphocytes is linked to surface expression of the T3 molecular complexCell, 1982